Correlation Between Alnylam Pharmaceuticals and Sangamo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alnylam Pharmaceuticals and Sangamo Therapeutics, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Sangamo Therapeutics.
Diversification Opportunities for Alnylam Pharmaceuticals and Sangamo Therapeutics
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Alnylam and Sangamo is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and Sangamo Therapeutics go up and down completely randomly.
Pair Corralation between Alnylam Pharmaceuticals and Sangamo Therapeutics
Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to generate 0.79 times more return on investment than Sangamo Therapeutics. However, Alnylam Pharmaceuticals is 1.27 times less risky than Sangamo Therapeutics. It trades about 0.23 of its potential returns per unit of risk. Sangamo Therapeutics is currently generating about 0.07 per unit of risk. If you would invest 24,055 in Alnylam Pharmaceuticals on November 9, 2024 and sell it today you would earn a total of 3,770 from holding Alnylam Pharmaceuticals or generate 15.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alnylam Pharmaceuticals vs. Sangamo Therapeutics
Performance |
| Timeline |
| Alnylam Pharmaceuticals |
| Sangamo Therapeutics |
Alnylam Pharmaceuticals and Sangamo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alnylam Pharmaceuticals and Sangamo Therapeutics
The main advantage of trading using opposite Alnylam Pharmaceuticals and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
| Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |